Geneodx Biotech

Located in Shanghai, Geneodx Biotech is a company focused on developing innovative biotechnology solutions, particularly in the health sector, to enhance diagnostics and treatment efficiency. Founded in 1991 in Shanghai, China, Geneodx Biotech specializes in biotechnology solutions. The company has undergone no significant pivots in its strategy and operates independently without subsidiaries. The latest funding round occurred in December 2025, where Geneodx Biotech raised approximately CNY 200 million from Huagai Capital.

The total amount raised to date stands at CNY 200 million. Geneodx Biotech offers a range of biotechnology products aimed at improving healthcare solutions. Their innovations are designed to optimize diagnostics and enhance treatment protocols, primarily targeting the healthcare sector to address challenges in medical data management and patient care efficiency. Their products have been well received in markets across North America, Europe, and Asia, catering to both healthcare providers and pharmaceutical companies.

Geneodx Biotech generates revenue through a structure focused on software subscriptions and licensing agreements. Clients engage with the company via annual subscriptions, offering access to a comprehensive suite of its biotechnology solutions. Collaborations with healthcare providers and institutions further enhance their revenue streams, with tiered pricing plans allowing clients to choose services tailored to their operational needs. The company intends to launch new biotechnology products aimed at enhancing diagnostic capabilities by December 2026.

Additionally, Geneodx Biotech plans to expand its market presence in Europe and North America within the next two years. The recent funding of CNY 200 million will support these initiatives, particularly in strengthening their core technologies and facilitating market expansion strategies.